Alignment Healthcare (NASDAQ:ALHC) President Sells $524,400.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the firm’s stock in a transaction on Monday, March 16th. The stock was sold at an average price of $17.48, for a total transaction of $524,400.00. Following the completion of the sale, the president owned 1,095,562 shares of the company’s stock, valued at $19,150,423.76. This trade represents a 2.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 12th, Dawn Christine Maroney sold 29,113 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.45, for a total transaction of $508,021.85.
• On Tuesday, February 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.63, for a total transaction of $618,900.00.
• On Thursday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $22.48, for a total transaction of $674,400.00.
• On Tuesday, January 6th, Dawn Christine Maroney sold 228,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $21.33, for a total value of $4,866,482.16.
• On Friday, January 2nd, Dawn Christine Maroney sold 100,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $20.03, for a total value of $2,003,000.00.
• On Monday, December 29th, Dawn Christine Maroney sold 282,070 shares of Alignment Healthcare stock. The stock was sold at an average price of $18.74, for a total value of $5,285,991.80.

Alignment Healthcare Price Performance

Alignment Healthcare stock traded up $0.41 during midday trading on Tuesday, reaching $17.92. The company’s stock had a trading volume of 2,947,535 shares, compared to its average volume of 2,922,050. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The company has a debt-to-equity ratio of 1.80, a quick ratio of 1.71 and a current ratio of 1.71. The firm has a market capitalization of $3.66 billion, a PE ratio of -1,790.21, a P/E/G ratio of 2.49 and a beta of 1.19. The stock’s 50 day simple moving average is $20.69 and its 200 day simple moving average is $18.78.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings results on Thursday, February 26th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.10. The business had revenue of $1.01 billion for the quarter, compared to analyst estimates of $1 billion. Alignment Healthcare had a negative return on equity of 0.49% and a negative net margin of 0.02%.The company’s quarterly revenue was up 44.4% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.16) EPS. On average, equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

Wall Street Analyst Weigh In

Several analysts have weighed in on ALHC shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Alignment Healthcare in a report on Wednesday, January 21st. Robert W. Baird set a $28.00 price objective on shares of Alignment Healthcare in a research report on Friday, January 30th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, March 7th. Piper Sandler raised their target price on shares of Alignment Healthcare from $20.00 to $30.00 and gave the company an “overweight” rating in a report on Tuesday, January 6th. Finally, TD Cowen upped their price target on shares of Alignment Healthcare from $18.50 to $25.00 and gave the company a “buy” rating in a report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $24.56.

Institutional Trading of Alignment Healthcare

A number of large investors have recently made changes to their positions in ALHC. Summit Securities Group LLC purchased a new stake in Alignment Healthcare during the 4th quarter worth about $26,000. Parallel Advisors LLC lifted its holdings in Alignment Healthcare by 87.7% in the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock valued at $33,000 after purchasing an additional 773 shares in the last quarter. Larson Financial Group LLC purchased a new position in Alignment Healthcare in the 3rd quarter valued at about $33,000. First Horizon Corp acquired a new stake in shares of Alignment Healthcare during the 4th quarter worth about $39,000. Finally, SBI Securities Co. Ltd. grew its holdings in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock worth $42,000 after buying an additional 2,970 shares in the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.